State Street’s THERAGENICS CORP TGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-30,181
Closed -$66K 3704
2013
Q3
$66K Sell
30,181
-100
-0.3% -$213 ﹤0.01% 3495
2013
Q2
$63K Buy
+30,281
New +$54.2K ﹤0.01% 3415

State Street's TGX Position: Q4 2013 in Review

State Street sold out of THERAGENICS CORP (TGX) in Q4 2013, closing a stake of 30,181 shares — an estimated $66K sold.

State Street first reported a position in TGX in Q2 2013 and held it in 2 quarters. The position peaked at $66K in Q3 2013. 0 funds tracked by Wall St. Rank hold TGX as of Q4 2013.

  • State Street reported no remaining THERAGENICS CORP position as of Q4 2013 after selling out during the quarter.
  • State Street sold 30,181 THERAGENICS CORP shares in Q4 2013, an estimated $66K.
  • State Street first reported a position in THERAGENICS CORP in Q2 2013 and held it in 2 quarters.
  • State Street's THERAGENICS CORP position peaked at $66K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held THERAGENICS CORP as of Q4 2013.

Based on State Street's 13F filing for Q4 2013, filed 6 Feb 2014.